Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 44.26 EUR 0.73% Market Closed
Market Cap: 26B EUR
Have any thoughts about
Fresenius Medical Care AG?
Write Note

Gross Margin
Fresenius Medical Care AG

25.3%
Current
27%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
25.3%
=
Gross Profit
4.9B
/
Revenue
19.4B

Gross Margin Across Competitors

Country DE
Market Cap 26B EUR
Gross Margin
25%
Country US
Market Cap 75.6B EUR
Gross Margin
11%
Country US
Market Cap 77.9B USD
Gross Margin
11%
Country US
Market Cap 56B USD
Gross Margin
14%
Country DE
Market Cap 18.8B EUR
Gross Margin
24%
Country US
Market Cap 19.3B USD
Gross Margin
28%
Country US
Market Cap 16.9B USD
Gross Margin
19%
Country US
Market Cap 17.1B USD
Gross Margin
33%
Country DE
Market Cap 13B EUR
Gross Margin
25%
Country US
Market Cap 12.7B USD
Gross Margin
33%
Country AU
Market Cap 13.2B AUD
Gross Margin
84%
No Stocks Found

Fresenius Medical Care AG
Glance View

Market Cap
26B EUR
Industry
Health Care

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
52.54 EUR
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
25.3%
=
Gross Profit
4.9B
/
Revenue
19.4B
What is the Gross Margin of Fresenius Medical Care AG?

Based on Fresenius Medical Care AG's most recent financial statements, the company has Gross Margin of 25.3%.